An innovative European PhD training network
Introduction
ABOUT THE NETWORK
BonePain II is a European training network for early stage researchers. BonePain II builds on a previous European Training Network on BonePain.
BonePain II is a European platform to promote frontline research, innovation and education within bone pain. Millions in Europe and beyond suffer from bone pain, which is a debilitating complication of many musculoskeletal disorders such as arthritis and bone metastasis.
The BonePain II network encompasses 8 academic groups and 4 industries all committed to creating an outstanding training program for early stages researchers to elucidate the mechanisms of bone pain and develop new medicines.
In an extensive training effort covering both specific research skills and transferable skills, the students will obtain an interdisciplinary, state-of-the-art and innovative training from the participants, several of which have experience from international networks. The students will benefit from secondments with industrial partners and with some of the foremost pain researchers in Europe.
EXPLORE
MEET OUR STUDENTS
We train independent, creative and innovative scientists by providing cutting-edge knowledge and a broad range of frontline scientific and transferable skills that make our PhD students top candidates across Europe for positions in the academic and non-academic sector.
EVENTS
The BonePain Network holds a series of network wide training events where beneficiaries, ESRs, partners and invited speakers will discuss the progress of the programme, meet one another and form collaborations and offer training courses on specific topics to the ESRs.
MEET THE PARTNERS
The BonePain Network encompasses 8 academic beneficiaries, 3 industrial beneficiaries and 1 industrial partner all committed to creating an outstanding training program for early stages researchers to elucidate the mechanisms of bone pain and develop new medicines.
The project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No 814244.